Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

VH Tam, AN Schilling, G Vo, S Kabbara… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Despite limited data, polymyxin B (PB) is increasingly used clinically as the last therapeutic
option for multidrug-resistant (MDR) gram-negative bacterial infections. We examined the in …

Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa

VH Tam, AN Schilling, S Neshat, K Poole… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Suppression of resistance in a dense Pseudomonas aeruginosa population has previously
been shown with optimized quinolone exposures. However, the relevance to β-lactams is …

Plumage brightness as an indicator of parental care in northern cardinals

SU Linville, R BREITWISCH, AMYJ SCHILLING - Animal Behaviour, 1998 - Elsevier
Good parent and differential allocation models predict relationships between degree of sexual
ornamentation and parental care, but relatively few studies have tested these models. The …

Modelling time–kill studies to discern the pharmacodynamics of meropenem

VH Tam, AN Schilling, M Nikolaou - Journal of antimicrobial …, 2005 - academic.oup.com
Objectives: Time–kill studies are commonly used in investigations of new antimicrobial
agents. However, they typically provide descriptive information on pharmacodynamics. We …

Comparative Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa

VH Tam, S Kabbara, G Vo, AN Schilling… - Antimicrobial agents …, 2006 - Am Soc Microbiol
Aminoglycosides are often used to treat severe infections with gram-positive organisms.
Previous studies have shown concentration-dependent killing by aminoglycosides of gram-…

Acetaminophen: old drug, new warnings.

A Schilling, R Corey, M Leonard… - Cleveland Clinic journal …, 2010 - europepmc.org
The US Food and Drug Administration (FDA), concerned about the incidence of acute liver
failure due to acetaminophen (Tylenol) overdose, has mandated new labeling on …

Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets

…, C Beadling, A Warrick, A Schilling… - Applied …, 2015 - journals.lww.com
Primary neuroendocrine carcinoma of the breast is a rare variant, accounting for only 2% to
5% of diagnosed breast cancers, and may have relatively aggressive behavior. Mutational …

Vancomycin: a 50-something-year-old antibiotic we still don't understand.

AMY Schilling, E Neuner, SJ Rehm - Cleveland Clinic journal of …, 2011 - europepmc.org
Because a significant proportion of Staphylococcus aureus strains as well as most
coagulase-negative staphylococci are resistant to penicillin and semisynthetic beta-lactam drugs, the …

Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa

VH Tam, KT Chang, MT LaRocco, AN Schilling… - … and infectious disease, 2007 - Elsevier
We examined the prevalence of various carbapenem resistance mechanisms in Pseudomonas
aeruginosa bloodstream isolates from a university-affiliated hospital. Isolates obtained in …

[HTML][HTML] Novel method for PIK3CA mutation analysis: locked nucleic acid–PCR sequencing

D Ang, R O'Gara, A Schilling, C Beadling… - The Journal of Molecular …, 2013 - Elsevier
Somatic mutations in PIK3CA are commonly seen in invasive breast cancer and several other
carcinomas, occurring in three hotspots: codons 542 and 545 of exon 9 and in codon 1047 …